Outset Medical, Inc. Common Stock (OM) Stock
NASDAQ · OM
2.90
Fundamentals
Market cap
$57.33M
Price / Earnings ratio
-0.8x
Price / Sales ratio
0.5x
Price / Book ratio
0.6x
Return on assets
-28.0%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.00%
Debt / Equity ratio
N/A
Recent news

Zacks Investment Research
Despite Fast-paced Momentum, Outset Medical (OM) Is Still a Bargain Stock
NeutralOMAugust 18, 2026
Zacks Investment ResearchNeutral
Despite Fast-paced Momentum, Outset Medical (OM) Is Still a Bargain Stock
OM

MarketBeat
Outset Medical Q2 Earnings Call Highlights
NeutralOMAugust 7, 2026
MarketBeatNeutral
Outset Medical Q2 Earnings Call Highlights
OM

Zacks Investment Research
Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates
NeutralOMAugust 6, 2026
Zacks Investment ResearchNeutral
Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates
OM

Zacks Investment Research
Outset Medical (OM) Surges 25.6%: Is This an Indication of Further Gains?
NeutralOMJune 19, 2026
Zacks Investment ResearchNeutral
Outset Medical (OM) Surges 25.6%: Is This an Indication of Further Gains?
OM
Technicals
OscillatorsBuy5 Indicators
Moving AveragesStrong Sell12 Indicators
Analyst Ratings
Strong Sell0
Sell0
Neutral0
Buy0
Strong Buy0
Financials
Performance
Revenue
Net income
Net margin %
2025
143M95M47M0
Debt & Balance Sheet
Total assets
Total liabilities
2025
317M209M105M0
Revenue to Profit
2025$119.5M
Revenue$0.0
Cost of revenue$0.0
Gross profit$0.0
Operating expenses$-81.7M
Net incomeEarnings
No data available
% positive news of 10 articles
published over the past 14 days
Latest news

Zacks Investment Research
Despite Fast-paced Momentum, Outset Medical (OM) Is Still a Bargain Stock
NeutralOMAugust 18, 2026
Zacks Investment ResearchNeutral
Despite Fast-paced Momentum, Outset Medical (OM) Is Still a Bargain Stock
OM

MarketBeat
Outset Medical Q2 Earnings Call Highlights
NeutralOMAugust 7, 2026
MarketBeatNeutral
Outset Medical Q2 Earnings Call Highlights
OM

Zacks Investment Research
Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates
NeutralOMAugust 6, 2026
Zacks Investment ResearchNeutral
Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates
OM

Zacks Investment Research
Outset Medical (OM) Surges 25.6%: Is This an Indication of Further Gains?
NeutralOMJune 19, 2026
Zacks Investment ResearchNeutral
Outset Medical (OM) Surges 25.6%: Is This an Indication of Further Gains?
OM

Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 2026
NeutralOMJune 14, 2026
Business WireNeutral
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 2026
OM

MarketBeat
Outset Medical Q1 Earnings Call Highlights
NeutralOMMay 8, 2026
MarketBeatNeutral
Outset Medical Q1 Earnings Call Highlights
OM

Zacks Investment Research
Outset Medical, Inc. (OM) Reports Q1 Loss, Lags Revenue Estimates
NeutralOMMay 7, 2026
Zacks Investment ResearchNeutral
Outset Medical, Inc. (OM) Reports Q1 Loss, Lags Revenue Estimates
OM

Zacks Investment Research
OM Stock Gains on FDA Clearance for Next-Gen Tablo Dialysis System
NeutralOMJanuary 28, 2026
Zacks Investment ResearchNeutral
OM Stock Gains on FDA Clearance for Next-Gen Tablo Dialysis System
OM

Zacks Investment Research
Outset Medical (OM) Soars 22.2%: Is Further Upside Left in the Stock?
NeutralOMJanuary 13, 2026
Zacks Investment ResearchNeutral
Outset Medical (OM) Soars 22.2%: Is Further Upside Left in the Stock?
OM

InvestorPlace
3 MedTech Stocks to Buy for Healthy Gains
NeutralOMJuly 1, 2024
InvestorPlaceNeutral
3 MedTech Stocks to Buy for Healthy Gains
OM
About Outset Medical, Inc. Common Stock
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
SectorHealthcare
IndustryMedical Devices
Employees310
CEOMs. Leslie L. Trigg
IPO DateSep 15, 2020
HeadquartersSan Jose, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Ms. Leslie L. Trigg | President, CEO & Chairman | 1971 |
| Ms. Renee M. Gaeta | CFO, Principal Financial Officer & Principal Accounting Officer | 1981 |
| Mr. John L. Brottem J.D. | General Counsel & Secretary | 1974 |
Fundamentals
Valuation
Market cap$57.33M
Price-to-sales ratio0.50
Price-to-book value0.61
Price-earnings ratio-0.80
Return on Equity-56.00%
Return on Sales-51.00%
Return on Assets-28.00%
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-4.00
Income Statement
Average volume133,448
EBITDA$-54.84M
1 year high (52w)$16.16
1 year low (52w)$3.00
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A
Technicals
OscillatorsBuy5 Indicators
Moving AveragesStrong Sell12 Indicators
What the experts say
0 Wall Street Analyst Ratings
N/A
0% Buy
0% Hold
0% Sell
Target price
$0.00
Est return
0.00%
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +1.7 | +8.1 | -19.0 | +2.7 | ||||||||
| 2022 | -21.3 | +15.9 | +4.1 | -25.8 | -40.6 | -29.0 | -1.3 | -6.7 | -9.4 | -5.6 | +45.4 | +16.7 |
| 2023 | +12.9 | -19.6 | -18.5 | -4.3 | +9.2 | +0.2 | -0.5 | -33.2 | -21.6 | -65.2 | +39.4 | -4.9 |
| 2024 | -46.1 | +5.7 | -28.2 | +21.6 | +30.9 | +0.8 | -3.8 | -84.9 | +28.3 | -9.8 | +46.9 | +22.6 |
| 2025 | -31.6 | -9.6 | +10.4 | -2.5 | +57.3 | +7.9 | -22.5 | -7.5 | +2.8 | -6.4 | -65.0 | -12.1 |
| 2026 | +35.4 | -29.8 | +7.6 | +11.2 | +12.2 | -12.0 | -10.4 | -23.4 | -16.2 |



